Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. EOSE
3. DLR
4. AVAV
5. MU
6. ENPH
7. ABVX
8. BAC
9. NVDA
10. VSH

Go back to Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q4 EPS by 9c

March 15, 2022 7:33 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q4 EPS of ($0.38), $0.09 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $4.8 million.

Cash and Financial Guidance:

Cash, cash equivalents and marketable securities as of December 31, 2021 were... More